IGFBP2 and central nervous system cancer: Both high levels of serum IGFBP-2 and high tissue expression IGFBP-2 by both IHC and mRNA levels correlate with poor PFS and OS in gliomas, including glioblastoma multiforme (GBM) (145–149).